天津科学技术出版社

单细胞 RNA 测序揭示多发性骨髓瘤中造血干细胞介导的免疫和造血重建

李倩 1,2,林丽 2,高爽 2,陈琳 2,张志影 2,马静 2,刘素 2,李楠 2,赵丽娜 2,曹增 1,赵海丰 1,王亚非 1,2 *
作者信息
  1. 1 天津医科大学肿瘤医院血液科,恶性肿瘤国家临床医学研究中心,天津市肿瘤防治重点实验室, 天津市恶性肿瘤临床医学研究中心,天津 300060
  2. 2 天津市肿瘤医院空港医院血液移植科,天津 300308
*通信作者

摘要

目的 系统性揭示高剂量化疗联合自体造血干细胞移植(auto-HSCT)过程中多发性骨髓瘤(MM)患者骨髓肿瘤微环境(TME)的动态重塑规律,特别是免疫重建、造血恢复及细胞间相互作用的演变过程。 方法 利用单细胞 RNA 测序(scRNA-seq)技术,对接受高剂量美法仑治疗及 auto-HSCT 的 MM 患者骨髓样本进行纵向分析,通过高分辨率解析移植前后骨髓细胞的转录组图谱。 结果 (1)绘制了免疫重建轨迹,发现前 B细胞、B 细胞、单核细胞、T 细胞和自然杀伤(NK) 细胞在移植后呈现特异性恢复模式,其基因表达谱显示代谢和免疫功能的重编程;(2)血管生成相关通路分析表明,健康供体的免疫细胞维持血管完整性,而 MM 患者的免疫细胞则表现出干扰素(IFN)-α/γ 信号通路的异常激活;(3)造血干细胞(HSC)分析显示 MM 微环境通过肿瘤坏死因子 α(TNF-α)/核因子-κB(NF-κB)通路诱导炎症重编程,而治疗可恢复造血平衡;(4)细胞间通讯分析揭示了 MM 中肿瘤特异性相互作用(如 TNFSF10-TNFRSF10B)形成的免疫抑制微环境,以及移植后免疫调节相互作用的恢复 ( 如LGALS9-CD45)。 结论 这些发现不仅为理解 MM auto-HSCT 的治疗机制提供了新的见解,也为开发针对免疫重建和微环境调控的联合治疗策略提供了理论依据,提示在移植后可能存在免疫调节治疗的窗口期。

Single- cell RNA sequencing reveals hematopoietic stem cell-mediated immune and hematopoietic reconstitution in multiple myeloma

Qian LI 1,2, Li LIN 2, Shuang GAO 2, Lin CHEN 2, Zhiying ZHANG 2, Jing MA 2, Su LIU 2, Nan LI 2, Lina ZHAO 2, Zeng CAO , Haifeng ZHAO 1, Yafei WANG 1,2,*
Author Information
  1. 1 Department of Hematology, Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center of Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060 , China
  2. 2 Department of Blood and Marrow Transplantation, Tianjin Cancer Hospital Airport Hospital, Tianjin 300308, China
*Corresponding author

Abstract

Objective This study aims to systematically reveal the dynamic remodeling patterns of the bone marrow tumor microenvironment (TME) in multiple myeloma (MM) patients during high-dose chemotherapy combined with autologous hematopoietic stem cell transplantation (auto-HSCT), particularly focusing on the evolution of immune reconstitution, hematopoietic recovery, and intercellular interactions.Methods This study employed single-cell RNA sequencing (scRNA-seq) technology to conduct longitudinal analysis of bone marrow samples from MM patients who received high-dose melphalan treatment and auto-HSCT, providing high-resolution profiling of the transcriptional landscape of bone marrow cells before and after transplantation. Results (1) Immune reconstitution trajectories were mapped, revealing specific recovery patterns of pre-B cells, B cells, monocytes, T cells, and natural killer (NK) cells after transplantation, with their gene expression profiles indicating reprogramming of metabolic and immune functions; (2) Analysis of angiogenesis-related pathways showed that immune cells from healthy donors maintained vascular integrity, while those from MM patients exhibited abnormal activation of the interferon (IFN)-α/γ signaling pathway; (3) Hematopoietic stem and progenitor cells (HSPCs) analysis indicated that the MM microenvironment induced inflammatory reprogramming through the tumor necrosis factor α(TNF-α) / nuclear factor-κB(NF-κB) pathway, and treatment restored hematopoietic balance; (4) Intercellular communication analysis revealed the formation of an immunosuppressive microenvironment in MM through tumor - specific interactions ( such as TNFSF10 -TNFRSF10B), as well as the restoration of immunomodulatory interactions after transplantation ( such as LGALS9-CD45). Conclusion These findings not only provide new insights into the therapeutic mechanism of MM auto-HSCT but also offer a theoretical basis for the development of combined treatment strategies targeting immune reconstitution and microenvironment regulation, suggesting a potential window for immunomodulatory therapy after transplantation.

再生医学研究 Copyright © 2026. All Rights Reserved